Press Releases

HAVN Life Announces Gary Leong’s Appointment to Board of Directors

Mr. Leong brings with him a wealth of scientific and regulatory experience Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to support brain health and enhance the capabilities of the mind, is pleased to announce …

HAVN Life Announces Gary Leong’s Appointment to Board of Directors Read More »

HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc.

The Subscription-based Functional Mushroom Company has established a significant consumer base in the U.S. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company developing natural health products and innovative therapies to support central nervous system health and enhance the capabilities of the mind, …

HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc. Read More »

HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes

The Company was able to export naturally derived psilocybin to their California-based Supply Partner, Mycrodose Therapeutics late last week. Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”), a biotechnology company pursuing standardized extraction of psychedelic compounds for investigational research as potential active pharmaceutical ingredients (APIs) …

HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes Read More »

HAVN Life To Present at upcoming SNN Network Canada Virtual Event

CEO Tim Moore to present and host a Q & A for investors on December 8 at 2:30pm EST Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”) a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health …

HAVN Life To Present at upcoming SNN Network Canada Virtual Event Read More »

HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada

The Company Signs Supply Agreement with Nectar Health Sciences Laboratory Division Inc. to provide naturally derived psilocybin for research and development of therapeutic products Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”) a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of …

HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada Read More »

HAVN Life Enters into Agreement to Distribute its Line of Natural Health Products with Australia’s Woke Pharmaceuticals

The Agreement gives Woke Pharmaceuticals exclusive White Label and Distribution rights to HAVN Life products in Australia, New Zealand and China through retail and e-commerce portals Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to …

HAVN Life Enters into Agreement to Distribute its Line of Natural Health Products with Australia’s Woke Pharmaceuticals Read More »

HAVN Life Announces Departure of Rick Brar as Director

Vancouver, BC – HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF) (FSE: 5NP)  (the “Company” or “HAVN Life”) announces the departure of Mr. Rick Brar as Vice-Chair of the board of directors of the Company (“Board”) and as a director of the Company, effective immediately. The Company expresses its appreciation for Mr. Brar’s services …

HAVN Life Announces Departure of Rick Brar as Director Read More »

HAVN Life Files Final Base Shelf Prospectus

Vancouver, BC – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) is pleased to announce that it has filed its final short form base shelf prospectus (the “Final Shelf Prospectus”) with the securities commissions in each of the provinces and territories of Canada and received a final receipt …

HAVN Life Files Final Base Shelf Prospectus Read More »

HAVN Life Acquires Bennett’s Choice Patented Brain Health and Recovery Formulations

HAVN Life Acquires Bennett’s Choice Patented Brain Health and Recovery Formulations

Along with adding new formulations to the Company’s natural health product portfolio, founder Matthew Bennett to join HAVN Life as Director of Education Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”)a biotechnology company developing natural health products and innovative therapies to support brain health and …

HAVN Life Acquires Bennett’s Choice Patented Brain Health and Recovery Formulations Read More »

HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics

The partnership is a integral step in the The Company’s path to market in the U.S., achieving one of its most important milestones to-date Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “Havn Life”)a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs …

HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics Read More »

Scroll to Top